Specificity of interaction between receptor and G protein: Use of antisense techniques to relate G-protein subunits to function

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1314, Issue 1-2, 1996, Pages 125-139

  Kalkbrenner, Frank ^a   Dippel, Edgar ^a   Wittig, Burghardt ^a   Schultz, Günter ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Antisense oligonucleotide; G protein heterotrimer; Nuclear microinjection; Receptor G protein interaction

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; CONTROLLED STUDY; DNA RNA HYBRIDIZATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TECHNIQUE;

ANIMALIA;

EID: 0030575941     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(96)00072-9     Document Type: Short Survey

References (78)

1. [1] Simon, M.I., Strathmann, M.P. and Gautam N. (1991) Science 232, 802-808.
2. [2] Birnbaumer, L. (1992) Cell 71, 1069-1072.
3. [3] Offermanns, S. and Schultz G. (1994) Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 329-338.
4. [4] Birnbaumer, L. and Birnbaumer, M.J. (1995) Signal Transduction Res. 15, 213-252.
5. [5] Neer E.J. (1995) Cell 80, 249-257.
6. [6] Milligan, G. (1995) Adv. Pharmacol. 32, 1-28.
7. [7] Nürnberg, B., Gudermann, T. and Schultz, G. (1995) J. Mol. Med. 73, 123-132.
8. [8] Gudermann, T., Kalkbrenner, F. and Schultz, G. (1996) Annu. Rev. Parmacol. Toxicol. 36, 429-459.
9. [9] Offermanns, S., Schultz, G. and Rosenthal, W. (1991) Meth. Enzymol. 195, 286-301.
10. [10] Laugwitz, K.-L., Spicher, K., Schultz, G. and Offermanns, S. (1994) Methods Enzymol. 237, 283-294.
11. [11] Fields, T.A., Linder, M.E. and Casey, P.J. (1994) Biochemistry 33, 6877-6883.
12. [12] Meinkoth, J.L., Goldsmith, P.K., Spiegel, A.M., Feramisco, J.R. and Burrow, G.N. (1992) J. Biol. Chem. 267, 13239-13245.
13. [13] Caulfield, M.P., Jones, S., Vallis, Y, Buckley, N.J., Kim, G.D., Milligan, G. and Brown, D.A. (1994) J. Physiol. (Lond.) 477, 415-422.
14. [14] Leprêtre, N., Mironeau, J., Arnaudeau, S., Tanfin, Z., Harbone, S., Guillon, G., and Ibarrondon, J. (1994) J. Pharmac. Exp. Ther. 268, 167-174.
15. [15] LaMorte, V.J., Goldsmith, P.K., Spiegel, A.M., Meinkoth, J.L. and Feramisco, J.R. (1992) J. Biol. Chem. 267, 691-694.
16. [16] Ting, T.D., Lee, R.H. and Ho, Y.-K. (1993) In: GTPase in Biology II (Dickey, B.F. and Birnbaumer, L., eds.), Handbook of Experimental Pharmacology 108/II, pp. 99-117, Springer, Berlin.
17. [17] Tang, W.J. and Gilman, A.G. (1992) Cell 70, 869-972.
18. [18] Park, D. (1993) In: GTPase in biology II (Dickey, B.F. and Birnbaumer, L., eds.), Handbook of Experimental Pharmacology 108/II, pp. 239-249, Springer, Berlin.
19. [19] Gierschik, P. and Camps, M. (1993) In: GTPase in Biology II (Dickey, B.F. and Birnbaumer, L., eds.), Handbook of Experimental Pharmacology 108/II, pp. 251-264, Springer, Berlin.
20. [20] Wickman, K.D., Iñiguez-Lluhi, J.A., Davenport, P.A., Taussig, R., Krapivinsky, G.B., Linder, M.E. Gilman, A.G. and Clapham, D.E. (1994) Nature 368, 255-257.
21. [21] Hescheler, J., Rosenthal, W., Trautwein, W. and Schultz, G. (1987) Nature 325, 445-447.
22. [22] Yatani, A., Codina, J., Imoto, Y., Reeves, J.P. Birnbaumer, L. and Brown, A.M. (1987) Science 238, 1288-1292.
23. [23] Man-Son-Hing, H.J., Codina, J., Abramowitz, J. and Haydon, P.G. (1992) Cell. Signalling 4, 429-441.
24. [24] Hélène, C. and Toulmé, J.-J. (1990) Biochim. Biophys. Acta 1049, 99-125.
25. [25] Crooke, S.T. (1992) Annu. Rev. Pharmacol. Toxicol. 32, 329-376.
26. [26] Crooke, S.T. (1993) FASEB J. 7, 533-539.
27. [27] Milligan, J.F., Matteucci, M.D. and Martin, J.C. (1993) J. Med. Chem. 36, 1923-1937.
28. [28] Crooke, R.S., Graham, M.J., Cooke, M.E. and Crooke, S.T. (1995) J. Pharm. Exp. Ther. 275, 462-473.
29. [29] Marshall, W.S. and Caruthers, M.H. (1993) Science 259, 1564-1570.
30. [30] Baertschi, A.J. (1994) Mol. Cell. Endocrinol. 101, R15-R24.
31. [31] Albert, P.R. and Morris, S.J. (1994) Trends Pharmacol. Sci. 15, 250-254.
32. [32] Liu, Y.F., Jakobs, K.H., Rasenick, M.M. and Albert, P.R. (1994) J. Biol. Chem. 269, 13880-13886.
33. [33] Goetzl, E.J., Shames, R.S., Yang, J., Birke, F.W., Liu, Y.F., Albert, P.R. and An, S. (1994) J. Biol. Chem. 269, 809-812.
34. [34] Chen, Y., Baez, M. and Yu, L. (1994) Neurosci. Lett. 179, 100-102.
35. [35] Paulssen, R.H., Paulssen, E.J, Gautvik, K.M. and Gordeladze, J.O. (1992) Eur. J. Biochem. 204, 413-418.
36. [36] Watkins, D.C., Johnson, G.L. and Malbon, C.C. (1992) Science 258, 1373-1375.
37. [37] Watkins, D.C., Moxham, C.M. Morris, A.J. and Malbon, C.C. (1994) Biochem. J. 299, 593-596.
38. [38] Moxam, C.M., Hod, Y. and Malbon, C.C. (1993) Science 260, 991-995.
39. [39] Moxam, C.M., Hod, Y. and Malbon, C.C. (1993) Devel. Genet. 14, 266-273.
40. [40] Moxam, C.M. and Malbon, C.C. (1996) Nature 379, 840-844.
41. [41] Tamemoto, H., Kadowaki, T., Tobe, F., Yagi, T., Sakura, H., Hayakawa, T., Terauchi, Y., Ueki, K., Kaburagi, Y., Satoh, S., Sekihara, H., Yoshioka, S., Horikoshi, H., Furuta, Y., Ikawa, Y., Kasuga, M., Yazaki, Y. and Aizawa, S. (1994) Nature 372, 182-186.
42. [42] Araki, E., Lipes, M.A., Patti, M.-E., Brünning J.C., Haag III, B., Johnson, R.S. and Kahn, R. (1994) Nature 372, 186-190.
43. [43] Mortensen, R.M. and Seidman, J.G. (1994) Meth. Enzymol. 237, 356-386.
44. [44] Rudolph, U., Finegold, M.J., Rich, S.S., Harriman, G.R., Srinivansan, Y., Brabet, P., Boulay, G., Bradley, A. and Birnbaumer, L. (1995) Nature Genet. 10, 143-150.
45. [45] Loke, S.L., Stein, C.A., Zhang, X.H., Mori, K., Nakanishi, M., Subashinghe, C., Cohen, J.S. and Neckers, L.M. (1989) Proc. Natl. Acad. Sci. USA 86, 3474-3478.
46. [46] ffrench-Mullen, J.M., Plata-Salaman, C.R., Buckley, N.J. and Danks, P. (1994) J. Physiol. (Lond.) 474, 21-26.
47. [47] Buckley, N.J., ffrench-Mullen, J. and Caulfield, M. (1995) Biochem. Soc. Trans. 23, 137-141.
48. [48] Wang, H.-Y., Watkins, D.C. and Malbon, C.C. (1992) Nature 358, 334-337.
49. [49] de Mazancourt, P., Goldsmith, P.K. and Weinstein, L.S. (1994) Biochem. J. 303, 369-375.
50. [50] Tang, T., Kiang, J.G., Côte, T.E. and Cox, B.M. (1995) Mol. Pharmacol. 48, 189-193.
51. [51] Bennet, F.C., Chiang, M.-Y., Chan, H., Shoemaker, J.E.E. and Mirabelli, C.K. (1992) Mol. Pharmacol. 41, 1023-1033.
52. [52] Crooke, S.T. (1995) Medical intelligence unit, R.G, Landes Co., Austin, Texas, USA.
53. [53] Baertschi, A.J., Audigier, Y., Lledo, P.-M., Israel, J.-M., Bockaert, J. and Vincent, J.-D. (1992) Mol. Endocrinol. 6, 2257-2265.
54. [54] Kleuss, C., Hescheler, J., Ewel, C., Rosenthal, W., Schultz, G. and Wittig, B. (1991) Nature 353, 43-48.
55. [55] Kleuss, C., Schultz, G. and Wittig, B. (1994) Meth. Enzymol. 237, 345-355.
56. [56] Kleuss, C., Scherübel, H., Hescheler, J., Schultz, G. and Wittig, B. (1992) Nature 358, 424.-426.
57. [57] Kleuss, C., Scherübel, H., Hescheler, J., Schultz, G. and Wittig, B. (1993) Science 259, 832-834.
58. [58] Degtiar, V.E., Wittig, B., Schultz, G. and Kalkbrenner, F. (1996) FEBS Lett. 380, 137-141.
59. [59] Kalkbrenner, F., Degtiar, V.E., Schenker, M., Brendel, S., Zobel, A., Hescheler, J., Wittig, B. and Schultz, G. (1995) EMBO J. 14, 4728-4737.
60. [60] Campell, V., Berrow, N. and Dolphin, A.C. (1993) J. Physiol. (Lond.) 470, 1-11.
61. [61] Degtiar, V.E., Wittig, B., Schultz, G. and Kalkbrenner, F. (1996) Meth. Mol. Biol. in press.
62. [62] Guvakova, M.A., Yakubov, L.A., Vlodavsky, I., Tonkinson, J.L. and Stein, C.A. (1995) J. Biol. Chem. 270, 2620-2627.
63. [63] Srinivasan, S.K., Tewary, H.K. and Iversen, P.L. (1995) Antisense Res. Dev. 5, 131-139.
64. [64] Barton, C.M. and Lemoine, N.R. (1995) Br. J. Cancer 71, 429-437.
65. [65] Burgess, T.L., Fisher, E.F., Ross, S.L., Gready, J.V., Qian, Y.-X., Bayewitch, L.A., Cohen, A.M., Herrera, C.J., Hu, S.S.-F., Kramer, T.B., Lott, F.D., Martin, F.H., Pierce, G.F., Simonet, L. and Farrell, C.F. (1995) Proc. Natl. Acad. Sci. USA 92, 4051-4055.
66. [66] Gollasch, M., Kleuss, C., Hescheler, J., Wittig, B. and Schultz, G. (1993) Proc. Natl. Acad. Sci. USA 90, 6265-6269.
67. [67] Dippel, E., Kalkbrenner, F., Wittig, B. and Schultz, G. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 1391-1396.
68. [68] Jones, S. V., Choi, O. H. and Beaven, M. A. (1991) FEBS Lett. 289, 47-50.
69. [69] Macrez-Leprêtre, N., Kalkbrenner, F., Schultz, G. and Mironneau, J. submitted.
70. [70] Neubig, R.R. (1994) FASEB J. 8, 939-946.
71. [71] Sargiacomo, M., Sudol, M., Tang, L.-Z. and Lisanti, M. P. (1993) J. Cell Biol. 122, 789-807.
72. [72] Chang, W.-J., Ying, Y.-S., Rothberg, K.G., Hooper, N.M., Turner, A.J., Gambiel, H.A., DeGunzburg, J., Mumby, S.M., Gilman, A.G. and Anderson, R.G.W. (1994) J. Cell Biol. 126, 127-138.
73. [73] Hansen, C.A., Schoering, A.G., Carey, D. J. and Robishaw, J.D. (1994) J. Cell. Biol. 126, 811-819.
74. [74] Kwon, G., Axelrod, D. and Neubig, R.R. (1994) Cell. Signalling 6, 663-679.
75. [75] Stehno-Bittel, L., Krapivinsky, G., Krapivinsky, L., Perez-Terzic, C. and Clapham, D. (1995) J. Biol. Chem. 270, 30068-30074.
76. [76] Shapira, H., Way, J., Lipinsky, D., Oron, Y. and Battey, J. (1994) FEBS Lett. 348, 89-92.
77. [77] Raffa, R.B., Martinez, R.P. and Connelly, C.D. (1994) Eur. J. Pharmacol. 258, R5-R7.
78. [78] Wahlestedt, C. (1994) Trends Pharmacol. Sci. 15, 42-46.